Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy.
作者信息
Rust Heiko, Kuhle Jens, Kappos Ludwig, Derfuss Tobias
机构信息
University Hospital Basel, Switzerland.
出版信息
Neurol Neuroimmunol Neuroinflamm. 2016 Mar 9;3(2):e215. doi: 10.1212/NXI.0000000000000215. eCollection 2016 Apr.
Abstract
摘要
相似文献
1
Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy.
Neurol Neuroimmunol Neuroinflamm. 2016 Mar 9;3(2):e215. doi: 10.1212/NXI.0000000000000215. eCollection 2016 Apr.
2
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
Lancet Neurol. 2009 Jun;8(6):519-29. doi: 10.1016/S1474-4422(09)70085-7. Epub 2009 May 4.
3
Natural history of multiple sclerosis: a unifying concept.
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.
4
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Gene. 2014 Jul 10;544(2):128-33. doi: 10.1016/j.gene.2014.04.069. Epub 2014 Apr 30.
5
Oral fingolimod for relapsing-remitting multiple sclerosis Evaluation of: Kappos L, Radue E-M, O'Connor P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010;362:387-401; and Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010;362:402-15.
Expert Opin Pharmacother. 2010 Jul;11(10):1777-81. doi: 10.1517/14656566.2010.481671.
6
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients.
J Neurochem. 2014 Aug;130(4):591-7. doi: 10.1111/jnc.12745. Epub 2014 May 28.
7
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Mult Scler. 2010 Jul;16(7):848-54. doi: 10.1177/1352458510369147. Epub 2010 May 20.
8
CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
Mult Scler. 2008 May;14(4):446-54. doi: 10.1177/1352458507085137. Epub 2008 Jan 21.
9
Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
J Neurol. 2004 May;251(5):542-7. doi: 10.1007/s00415-004-0360-0.
10
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Lancet Neurol. 2010 Jul;9(7):672-80. doi: 10.1016/S1474-4422(10)70132-0. Epub 2010 Jun 9.
引用本文的文献
1
Cytokine Profiling in Cerebrospinal Fluid of Patients with Newly Diagnosed Relapsing-Remitting Multiple Sclerosis (RRMS): Associations between Inflammatory Biomarkers and Disease Activity.
Int J Mol Sci. 2024 Jul 5;25(13):7399. doi: 10.3390/ijms25137399.
2
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis.
Biomolecules. 2022 Jan 27;12(2):222. doi: 10.3390/biom12020222.
3
Innate immunity impacts social-cognitive functioning in people with multiple sclerosis and healthy individuals: Implications for IL-1ra and urinary immune markers.
Brain Behav Immun Health. 2021 Apr 14;14:100254. doi: 10.1016/j.bbih.2021.100254. eCollection 2021 Jul.
4
Severe Delayed-Onset Neutropenia Induced by Ocrelizumab.
Neurohospitalist. 2021 Jan;11(1):59-61. doi: 10.1177/1941874420936438. Epub 2020 Jul 9.
5
Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis.
Front Immunol. 2020 Mar 5;11:174. doi: 10.3389/fimmu.2020.00174. eCollection 2020.
6
Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.
JCI Insight. 2019 Apr 2;5(9):126520. doi: 10.1172/jci.insight.126520.
7
The Emerging Role of Neutrophil Granulocytes in Multiple Sclerosis.
J Clin Med. 2018 Dec 3;7(12):511. doi: 10.3390/jcm7120511.
8
Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
Glia. 2018 Dec;66(12):2589-2603. doi: 10.1002/glia.23513. Epub 2018 Oct 16.
9
Adrenocorticotropic hormone methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial.
Ther Adv Neurol Disord. 2017 Jan;10(1):3-17. doi: 10.1177/1756285616670060. Epub 2016 Oct 19.
10
Gestational bisphenol-A exposure lowers the threshold for autoimmunity in a model of multiple sclerosis.
Proc Natl Acad Sci U S A. 2017 May 9;114(19):4999-5004. doi: 10.1073/pnas.1620774114. Epub 2017 Apr 24.
本文引用的文献
1
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
Ther Adv Neurol Disord. 2015 Sep;8(5):233-8. doi: 10.1177/1756285615594575.
2
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
Neurol Neuroimmunol Neuroinflamm. 2015 May 21;2(4):e117. doi: 10.1212/NXI.0000000000000117. eCollection 2015 Aug.
3
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells.
Nat Commun. 2014 Oct 3;5:5056. doi: 10.1038/ncomms6056.
4
Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
J Neuroinflammation. 2011 Jun 24;8:73. doi: 10.1186/1742-2094-8-73.
5
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
Nat Immunol. 2011 Jun;12(6):560-7. doi: 10.1038/ni.2027. Epub 2011 Apr 24.
6
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
J Exp Med. 2001 Oct 1;194(7):873-82. doi: 10.1084/jem.194.7.873.
7
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor.
Neurology. 2000 Jun 13;54(11):2147-50. doi: 10.1212/wnl.54.11.2147.
Zotero 插件